BRIDGEWATER, N.J.--(BUSINESS WIRE)--Promius Pharma, LLC has announced the launch of Promiseb™ Topical Cream, a non-steroidal, prescription only, cream for the treatment of seborrheic dermatitis, that has demonstrated both anti-inflammatory and antifungal properties. Promiseb Cream has been clinically shown to treat seborrheic dermatitis with comparable efficacy and fewer relapses than a low-potency topical corticosteroid in a randomized clinical study. Promius Pharma will begin promotion of Promiseb Cream at the Summer Meeting of the American Academy of Dermatology.
